PharmaCorp Expands with New Canadian Pharmacy Acquisition

Pharmacorp Rx Inc. (TSE:PCRX) has released an update.

PharmaCorp Rx Inc. has agreed to purchase a 90% interest in a Western Canadian pharmacy for $2.2 million, aiming to strengthen its market presence and maintain high service standards. The deal, planned to close by August 30, 2024, includes the continued involvement of the previous owners, with one becoming the managing pharmacist under a long-term agreement.

For further insights into TSE:PCRX stock, check out TipRanks’ Stock Analysis page.